Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Functional characterization of the different oligomeric forms of human surfactant protein SP-D
Introduction
Surfactant protein D (SP-D) is a hydrophilic protein which belongs to the collectin family [1,2]. SP-D participates in the innate immune defense of the lungs, opsonizing and promoting the clearance of invading pathogens. In addition, it participates in the regulation of the innate immune response [[3], [4], [5]]. Moreover, SP-D interacts with different receptors in inflammatory cells, regulating the release of proinflammatory mediators [2,[6], [7], [8], [9], [10], [11]]. SP-D have been also found in other mucosa in the body outside the lungs [11,12], mediating in the inflammatory response [2,13]. In addition, SP-D is implicated in the homeostasis and pool sizes of surfactant phospholipids [14,15].
SP-D monomer encloses four structural domains: the N-terminal domain, the collagen domain, the neck domain and the carbohydrate recognition domain (CRD) [4]. It has been described that SP-D is assembled in trimers – the minimal protein unit found in vivo and in vitro-, hexamers, dodecamers and large order oligomers (so called “fuzzy balls”) [1,16], with the hexamers very recently recognized as a defined oligomeric form of the protein [16]. The carbohydrate recognition domain (CRD) of SP-D, at the C-terminal end, is a key element for the majority of the protein functions. In the presence of calcium, SP-D recognizes principally carbohydrate structures in microorganisms and interact with them through the CRD [5,17].
Previous studies have attempted to isolate SP-D oligomers. In one of them, the isolation was performed using human protein (hSP-D) purified from amniotic fluid, but the resolution was limited to distinguish between low molecular weight oligomeric forms (trimers and possibly hexamers), and high molecular weight oligomers (dodecamers and fuzzy balls) [18,19]. In another study, Hartshorn and colleagues reported the isolation of recombinant human rhSP-D dodecamers and fuzzy balls, but their comparison was limited and it did not include the lower order oligomers [20].
Virus, bacteria, fungi, as well as receptors in inflammatory cells or products released by them, for example neutrophil extracellular traps (NETs), have been defined as SP-D ligands in vivo [2,4,[21], [22], [23]]. Influenza A virus (IAV) and some bacterial species, such as Escherichia coli, have been the most studied SP-D ligands in the literature [4,5]. SP-D recognizes carbohydrate structures at microbial surfaces and binds to them, inducing aggregation and opsonization of the infectious particles [11,24]. Therefore, both, bacteria and virus have been used for evaluating protein activity. The functional activity of isolated oligomeric forms of SP-D has been assessed mainly through binding assays to purified ligands, like lipopolysaccharide (LPS) or carbohydrates, IAV and bacteria. Also, virus aggregation assays have been performed. In general terms, the main conclusion obtained seem to be that large oligomers have a higher binding affinity [18], with the fuzzy balls exhibiting higher potency to aggregate IAV compared to dodecamers [20].
Despite these previous studies, it is unknown whether the different SP-D oligomeric forms could be selectively involved in certain protein functions, or whether they exhibit individually different potency to carry out specific roles. In addition, it is unknown if the SP-D hexamer has activity that is similar to the SP-D trimer or similar to higher order SP-D oligomers.
The purpose of this work has been to isolate the different oligomeric forms of recombinant human rhSP-D in order to evaluate and compare their functional activity. In particular, we pursued to achieve a higher degree of fractionation than just separating low versus high molecular weight oligomeric forms, obtaining if possible isolated trimers, hexamers, dodecamers and fuzzy balls in a sufficient amount to carry out functional assays. An additional objective was to define whether the hexamers recently found were functional structures or just an intermediate in protein oligomerization. We successfully obtained fractions highly enriched in trimers, hexamers and fuzzy balls. Fuzzy balls were the most active oligomeric form with respect to bacterial binding and aggregation assays. Hexamers triggered bacteria aggregation, although with less potency than fuzzy balls, and trimers were not sufficient to induce bacteria aggregation.
Section snippets
Production and purification of recombinant human SP-D (rhSP-D)
Full length rhSP-D (Met11, Thr160, Ser260) was synthesized by Chinese hamster ovary (CHO) cells and purified in two-steps chromatography columns.
Production and purification of recombinant human SP-D
Recombinant human SP-D (rhSP-D), variant Met11 Thr160 Ser270, was produced in mammalian CHO cells as described in methods. Purification of rhSP-D is usually performed by two consecutive chromatographic steps. First, an anion exchange column, which allows us to concentrate the sample and remove glucose from cell media. As a second step, a carbohydrate affinity column removes non-specific proteins and specifically retains SP-D, ending with the elution of pure SP-D [25].
A modified approach was
Discussion
The activity of the different oligomeric forms of SP-D has been a matter of discussion since it was found that the protein is assembled into different structures. Activity of non-truncated rhSP-D oligomeric forms has been addressed in the literature comparing two groups: low versus high molecular weight oligomeric forms, rather than the individual isolated oligomers. Herein we have been able to separate trimers, hexamers and fuzzy balls of a recombinant human rhSP-D. We have been able to
Conclussions
In summary, we have achieved the separation of a native full length recombinant human rhSP-D oligomeric forms. Isolation of trimers, hexamers and fuzzy balls was particularly efficient. Fuzzy balls presented a higher affinity of binding and a higher potency to aggregate bacteria than any other protein variant, which postulate them as the most active oligomeric form with respect to those protein functions that depend on the lectin activity. Hexamers were also active protein structures, while
Authors contributions
R.A., P.S.K. designed the study. R.A. performed experiments. R.A., M.E., J.P.-G., P.S.K. designed experiments and analyzed data. M.E., J.P.-G., F.M.-H. and P.S.K. provided scientific advice and helped to write the manuscript. All authors interpreted and discussed the data, reviewed the manuscript and had final approval of the submitted version.
Declaration of Competing Interest
Paul Kingma is a paid consultant for Airway Therapeutics Inc. which is developing SP-D as a human therapeutic agent.
Acknowledgements
This work has been supported by grants from the Spanish Ministry of Science and Innovation (RTI2018-094564-B-I00 to J.P.-G) and the Regional Government of Madrid (P2018/NMT4389 to J.P.-G.) F.M.-H. Acknowledges support from the Spanish Ministry of Science Innovation and Universities (project BFU2017-83794-P, (AEI/FEDER, UE)) and from the European Research Council (ERC) under the European Union Horizon 2020 research and innovation (grant agreement No 681299). R.A. acknowledges an FPU PhD
References (38)
- et al.
Molecular structure of pulmonary surfactant protein D (SP-D)
J. Biol. Chem.
(1994) - et al.
In defense of the lung: surfactant protein a and surfactant protein D
Curr. Opin. Pharmacol.
(2006) Structure, biologic properties, and expression of surfactant protein D (SP-D)
Biochim. Biophys. Acta
(1998)- et al.
Structure, genetics and function of the pulmonary associated surfactant proteins a and D: the extra-pulmonary role of these C type lectins
Ann. Anat.
(2017) - et al.
Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo
J. Biol. Chem.
(1998) - et al.
Supramolecular assembly of human pulmonary surfactant protein SP-D
J. Mol. Biol.
(2018) - et al.
High-resolution structural insights into ligand binding and immune cell recognition by human lung surfactant protein D
J. Mol. Biol.
(2003) - et al.
Multimeric and trimeric subunit SP-D are interconvertible structures with distinct ligand interaction
Mol. Immunol.
(2009) - et al.
Surfactant protein A and surfactant protein D variation in pulmonary disease
Immunobiology
(2007) - et al.
The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity
Mol. Immunol.
(2005)
Correction of pulmonary abnormalities in Sftpd−/− mice requires the collagenous domain of surfactant protein D
J. Biol. Chem.
Probing native protein structures by chemical cross-linking, mass spectrometry, and bioinformatics
Mol. Cell. Proteomics
Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly
J. Biol. Chem.
Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion
J. Biol. Chem.
Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties
J. Biol. Chem.
Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure
J. Biol. Chem.
Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation
Chest
Surfactant protein D in respiratory and non-respiratory diseases
Front Med (Lausanne)
Surfactant protein-D and pulmonary host defense
Respir. Res.
Cited by (10)
Goose surfactant protein A inhibits the growth of avian pathogenic Escherichia coli via an aggregation-dependent mechanism that decreases motility and increases membrane permeability
2023, Developmental and Comparative ImmunologyCitation Excerpt :Members of this group include hydrophilic surfactant protein A (SP-A) and D (SP-D), secreted by the alveolar epithelium to the alveolar fluid (Oberley and Snyder, 2003; Wu et al., 2003; Kishore et al., 2006; Floros and Tsotakos, 2021). SP-A and SP-D can bind to several microorganisms, which results in pathogen aggregation and/or killing and enhances phagocytosis of pathogens by alveolar macrophages (Wu et al., 2003; Hughes, 2007; Zhang et al., 2017; Arroyo et al., 2020). However, the functional and structural features of SP-A from geese are still not fully understood.
Surfactant protein D inhibits growth, alters cell surface polysaccharide exposure and immune activation potential of Aspergillus fumigatus
2022, The Cell SurfaceCitation Excerpt :The degree of oligomerization of SP-D was shown to be proportional to its C-type lectin activity. SP-D with higher degree of oligomerization is more efficient in binding to and aggregation of microbial pathogens (Arroyo et al., 2020a; Zhang et al., 2001). The difference in the A. fumigatus growth inhibitory abilities of FL-SP-D and rfhSP-D was also consistently observed in this study.
A recipe for a good clinical pulmonary surfactant
2022, Biomedical JournalCitation Excerpt :An additional avenue for improvement of materials amenable for SRT includes the incorporation of the hydrophilic surfactant proteins SP-A or SP-D. These proteins not only complement surfactant from the point of view of the protection against pathogens, but exhibit conspicuous anti-inflammatory properties [29,130,131]. Recombinant versions of human collectins SP-A and SP-D have been already produced [132,133], making feasible the production of more complete humanized surfactant preparations, with enhanced properties in the framework of certain pathologies such as bronchopulmonary dysplasia [134].
Characterization of Oligomer Formation of Surfactant Protein-D (SP-D) Using AF4-MALLS
2022, Current Protein and Peptide ScienceRole of surfactant protein-D in ocular bacterial infection
2022, International OphthalmologyMalondialdehyde Acetaldehyde-Adduction Changes Surfactant Protein D Structure and Function
2022, Frontiers in Immunology
- 1
Jesus Perez-Gil and Paul S. Kingma contributed equally to this work.